A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Multi-Purpose COVID Research Proposal

Authors

  • Jerard Seghatchian International Consultancy in Innovative Manufacturing And Quality/Safety of Blood-Derived Bioproducts, London, England, UK

DOI:

https://doi.org/10.6000/1927-520X.2021.10.07

Abstract

.

References

Seghatchian J. Editorial: An introductory commentary on the use of artificial intelligence, machine learning, and TQM as novel computational tools in big data patterns or procedural analysis in transfusion medicine. Transfus Apher Sci 2020; 59: 102985. https://doi.org/10.1016/j.transci.2020.102985

Seghatchian J. New generation of vaccines and convalescent plasma therapy for the management of CoV-2, in the global pandemic. Trans Apher Sci 2021; 103064. https://doi.org/10.1016/j.transci.2021.103064

Seghatchian J. Commentary: Fact and challenges on the global deployment of vaccines for the Immunotherapy of the evolving SARRS CoV-2 variants from the UK perspectives. Trends in Transplant 2021; 14: 1-4.

Seghatchian J, Acker JP, Putter JS. Update on newer approaches to prevent or treat COVID-19 infection: what we all need the most right now. Transfus Apher Sci 2020; 102933. https://doi.org/10.1016/j.transci.2020.102933

Seghatchian J, Lanza F. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: Arousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci 2020; 59(3): 102794. https://doi.org/10.1016/j.transci.2020.102794

Putter JS, Seghatchian J. An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy, and vaccine research. Transfus Apher Sci.

Amiral J, Vissac AM, Seghatchian J. COVID-19, induced activation of hemostasis and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients. Transfus Apher Sci 2020; 59(3): 102804. https://doi.org/10.1016/j.transci.2020.102804

Downloads

Published

2021-06-17

How to Cite

Seghatchian, J. . (2021). A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Multi-Purpose COVID Research Proposal. Journal of Buffalo Science, 10, 50–51. https://doi.org/10.6000/1927-520X.2021.10.07

Issue

Section

Articles